Progestogens stimulate prostacyclin production by human endothelial cells

Human Reproduction

Volumn 20, Issue 6, 2005, Pages 1554-1561

  Hermenegildo, Carlos ^a,b,c   Oviedo, P J ^b   Garcia Martinez M C ^b   Garcia Perez M A ^a   Tarin J J ^b   Cano, A ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Cyclooxygenase; Endothelial function; Hormones; Prostaglandins; Vasoactive agents

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ESTRADIOL; GESTAGEN; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; MIFEPRISTONE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROGESTERONE; PROGESTERONE RECEPTOR; PROSTACYCLIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG POTENTIATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYPOTHESIS; NUCLEOTIDE SEQUENCE; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TIME; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 20744442459     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh803     Document Type: Article

References (44)

1. Adams MR, Register TC, Golden DL, Wagner JD and Williams JK (1997) Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol 17,217-221.
2. Akarasereenont P, Techatraisak K, Thaworn A and Chotewuttakorn S (2000) The induction of cyclooxygenase-2 by 17beta-estradiol in endothelial cells is mediated through protein kinase C. Inflamm Res 49,460-465.
3. Cano A (1999) Progestins and coronary heart disease. Hum Reprod Update 5,189-190.
4. Dubey RK, Oparil S, Imthurn B and Jackson EK (2002) Sex hormones and hypertension. Cardiovasc Res 53,688-708.
5. Ganz P (2002) Vasomotor and vascular effects of hormone replacement therapy. Am J Cardiol 90,F11-F16.
6. Graham JD and Clarke C (2002) Progesterone receptors - animal models and cell signaling in breast cancer: expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells. Breast Cancer Res 4,187-190.
7. Habermehl DA, Janowiak MA, Vagnom KE, Bird IM and Magness RR (2000) Endothelial vasodilator production by uterine and systemic arteries. IV. Cyclooxygenase isoform expression during the ovarian cycle and pregnancy in sheep. Biol Reprod 62,781-798.
8. Herrington DM and Klein KP (2003) Randomized clinical trials of hormone replacement therapy for treatment or prevention of cardiovascular disease: a review of the findings. Atherosclerosis 166,203-212.
9. Jaffe EA, Nachman RL, Becker CG and Minick CR (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52,2745-2756.
10. Janowiak MA, Magness RR, Habermehl DA and Bird IM (1998) Pregnancy increases ovine uterine artery endothelial cyclooxygenase-1 expression. Endocrinology 139,765-771.
11. Jun SS, Chen Z, Pace MC and Shaul PW (1998) Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium. J Clin Invest 102,176-183.
12. Jun SS, Chen Z, Pace MC and Shaul PW (1999) Glucocorticoids downregulate cyclooxygenase-1 gene expression and prostacyclin synthesis in fetal pulmonary artery endothelium. Circ Res 84,193-200.
13. Karas RH, van Eickels M, Lydon JP, Roddy S, Kwoun M, Aronovitz M, Baur WE, Conneely O, O'Malley BW and Mendelsohn ME (2001) A complex role for the progesterone receptor in the response to vascular injury. J Clin Invest 108,611-618.
14. Kawano H, Motoyama T, Hirai N, Yoshimura. T, Kugiyama K, Ogawa H, Okamura H and Yasue H (2001) Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal women. Am J Cardiol 87,238-240.
15. Kim JJ, Wang J, Bambra C, Das SK, Dey SK and Fazleabas AT (1999) Expression of cyclooxygenase-1 and -2 in the baboon endometrium during the menstrual cycle and pregnancy. Endocrinology 140,2672-2678.
16. Kuller LH (2003) Hormone replacement therapy and risk of cardiovascular disease: implications of the results of the Women's Health Initiative. Arterioscler Thromb Vasc Biol 23,11-16.
17. Lewis GD, Campbell WB and Johnson AR (1986) Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cells. Endocrinology 119,62-69.
18. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 196,265-275.
19. Ma W, Tan J, Matsumoto H, Robert B, Abrahamson DR, Das SK and Dey SK (2001) Adult tissue angiogenesis: evidence for negative regulation by estrogen in the uterus. Mol Endocrinol 15,1983-1992.
20. Matsumoto H, Ma W, Daikoku T, Zhao X, Paria BC, Das SK, Trzaskos JM and Dey SK (2002) Cyclooxygenase-2 differentially directs uterine angiogenesis during implantation in mice. J Biol Chem 277,29260-29267.
21. McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA and FitzGerald GA (1999) Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 96,272-277.
22. Mendelsohn ME and Karas RH (1999) The protective effects of estrogen on the cardiovascular system. New Engl J Med 340,1801-1811.
23. Mikkola T, Turunen P, Avela K, Orpana A, Viinikka L and Ylikorkala O (1995) 17 beta-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. J Clin Endocrinol Metab 80,1832-1836.
24. Mikkola T, Ranta V, Orpana A, Viinikka L and Ylikorkala O (1996a) Hormone replacement therapy modifies the capacity of plasma and serum to regulate prostacyclin and endothelin-1 production in human vascular endothelial cells. Fertil Steril 66,389-393.
25. Mikkola T, Ranta V, Orpana A, Ylikorkala O and Viinikka L (1996b) Effect of physiological concentrations of estradiol on PGI2 and NO in endothelial cells. Maturitas 25,141-147.
26. Mikkola T, Viinikka L and Ylikorkala O (2000) Administration of transdermal estrogen without progestin increases the capacity of plasma and serum to stimulate prostacyclin production in human vascular endothelial cells. Fertil Steril 73,72-74.
27. Minshall RD, Stanczyk FZ, Miyagawa K, Uchida B, Axthelm M, Novy M and Hermsmeyer K (1998) Ovarian steroid protection against coronary artery hyperreactivity in rhesus monkeys. J Clin Endocrinol Metab 83, 649-659.
28. Mueck AO, Seeger H and Wallwiener D (2002) Medroxyprogesterone acetate versus norethisterone: effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell cultures. Menopause 9,273-281.
29. Ospina JA, Duckles SP and Krause DN (2003) 17beta-Estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilation. Am J Physiol Heart Circ Physiol 285,H241-H250.
30. Otsuki M, Saito H, Xu X, Sumitani S, Kouhara H, Kishimoto T and Kasayama S (2001) Progesterone, but not medroxyprogesterone, inhibits vascular cell adhesion molecule-1 expression in human vascular endothelial cells. Arterioscler Thromb Vasc Biol 21,243-248.
31. Parente L and Perretti M (2003) Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight. Biochem Pharmacol 65,153-159.
32. Ross R (1999) Atherosclerosis: an inflammatory disease. New Engl J Med 340,115-126.
33. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 288,321-333.
34. Rupnow HL, Phernetton TM, Modrick ML, Wiltbank MC, Bird IM and Magness RR (2002) Endothelial vasodilator production by uterine and systemic arteries. VIII. Estrogen and progesterone effects on cPLA2, COX-1, and PGIS protein expression. Biol Reprod 66,468-474.
35. Sarrel PM (1999) The differential effects of oestrogens and progestins on vascular tone. Hum Reprod Update 5,205-209.
36. Selles J, Polini N, Alvarez C and Massheimer V (2002) Nongenomic action of progesterone in rat aorta: role of nitric oxide and prostaglandins. Cell Signal 14,431-436.
37. Smith WL, DeWitt DL and Garavito RM (2000) Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69,145-182.
38. Tatsumi H, Kitawaki J, Tanaka K, Hosoda T and Honjo H (2002) Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins. Maturitas 42,287-294.
39. Vazquez F, Rodriguez-Manzaneque JC, Lydon JP, Edwards DP, O'Malley BW and Iruela-Arispe ML (1999) Progesterone regulates proliferation of endothelial cells. J Biol Chem 274,2185-2192.
40. White RE (2002) Estrogen and vascular function. Vasc Pharmacol 38,73-80.
41. White MM, Zamudio S, Stevens T, Tyler R, Lindenfeld J, Leslie K and Moore LG (1995) Estrogen, progesterone, and vascular reactivity: potential cellular mechanisms. Endocr Rev 16,739-751.
42. Winkler UH (1999) Effects of progestins on cardiovascular diseases: the haemostatic system. Hum Reprod Update 5,200-204.
43. Writing Group for the PEPI Trial (1995) Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. J Am Med Assoc 273,199-208.
44. Xu X, Otsuki M, Sumitani S, Saito H, Kouhara H and Kasayama S (2002) RU486 antagonizes the inhibitory effect of peroxisome proliferator-activated receptor α on interleukin-6 production in vascular endothelial cells. J Steroid Biochem Mol Biol 81,141-146.